Stay updated on Ralinepag Efficacy in PAH Patients Clinical Trial
Sign up to get notified when there's something new on the Ralinepag Efficacy in PAH Patients Clinical Trial page.

Latest updates to the Ralinepag Efficacy in PAH Patients Clinical Trial page
- Check4 days agoChange DetectedUpdated the study record with new dates: 2026-02-19 and 2026-02-20 were added, while 2026-02-05 and 2026-02-06 were removed.SummaryDifference0.1%

- Check11 days agoChange Detected- The page now displays Revision: v3.4.2, replacing the previous v3.4.1. This is a minor metadata update and does not alter study content or results.SummaryDifference0.0%

- Check18 days agoChange DetectedNew trial sites were added across Argentina, Bulgaria, France, Hungary, Italy, Portugal, Singapore, Spain, and Taiwan, and many previously listed locations were removed.SummaryDifference2%

- Check32 days agoChange DetectedShow glossary is now enabled and the page now displays 'Last Update Submitted that Met QC Criteria' and 'Last Update Posted'. No FEAR Act Data is displayed and the site revision has been updated from v3.3.4 to v3.4.0.SummaryDifference0.1%

- Check39 days agoChange DetectedStudy status updated to Completed and the Active, not recruiting designation removed, indicating enrollment is closed. Enrollment reached 728 participants and the page shows a revision to v3.3.4 with the last update posted on 2026-01-09.SummaryDifference0.3%

- Check68 days agoChange DetectedThe Locations section was expanded to include numerous site locations across the United States and internationally. This broadens enrollment options for potential participants.SummaryDifference3%

Stay in the know with updates to Ralinepag Efficacy in PAH Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ralinepag Efficacy in PAH Patients Clinical Trial page.